| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.52e-07 | 18 | 84 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.52e-06 | 28 | 84 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.73e-05 | 37 | 84 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.53e-05 | 14 | 84 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 5.23e-05 | 3 | 84 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 5.23e-05 | 3 | 84 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 1.04e-04 | 4 | 84 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate binding | 1.04e-04 | 4 | 84 | 2 | GO:0000822 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 1.20e-04 | 23 | 84 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.73e-04 | 5 | 84 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.73e-04 | 5 | 84 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.16e-04 | 70 | 84 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | POU domain binding | 3.62e-04 | 7 | 84 | 2 | GO:0070974 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 5.88e-04 | 39 | 84 | 3 | GO:0031369 | |
| GeneOntologyMolecularFunction | tRNA (cytidine) methyltransferase activity | 7.70e-04 | 10 | 84 | 2 | GO:0016427 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 9.57e-04 | 46 | 84 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.32e-03 | 13 | 84 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.55e-03 | 118 | 84 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.15e-03 | 129 | 84 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 2.28e-03 | 17 | 84 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.25e-03 | 343 | 84 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.44e-03 | 465 | 84 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.80e-03 | 151 | 84 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.89e-03 | 152 | 84 | 4 | GO:0022843 | |
| GeneOntologyBiologicalProcess | neuron projection retraction | 2.69e-07 | 4 | 85 | 3 | GO:0106028 | |
| GeneOntologyBiologicalProcess | neuron projection development | ADCY10 PLXNA3 CACNA1F KAT2B ZNF296 SNAP91 MYCBP2 TRIM32 USP9X ENC1 VPS13A DIAPH1 DIAPH2 POU3F2 SPG11 TECTA PLS1 RUFY3 | 3.95e-06 | 1285 | 85 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X VPS13A DIAPH1 DIAPH2 PDZD8 POU3F2 SPG11 PRKDC TECTA PLS1 CDH7 RUFY3 | 6.21e-06 | 1194 | 85 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X DIAPH1 DIAPH2 POU3F2 SPG11 TECTA PLS1 RUFY3 | 1.12e-05 | 748 | 85 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | cilium movement | 1.23e-05 | 261 | 85 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | axon development | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 TRIM32 USP9X DIAPH1 DIAPH2 POU3F2 SPG11 RUFY3 | 1.23e-05 | 642 | 85 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | developmental growth | ADCY10 PLXNA3 CACNA1C MYCBP2 USP9X VPS13A POU3F2 SPG11 POU5F1 POU5F1B PRKDC ATM PLS1 RUFY3 | 1.99e-05 | 911 | 85 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | axonogenesis | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X DIAPH1 DIAPH2 POU3F2 SPG11 RUFY3 | 2.05e-05 | 566 | 85 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron development | ADCY10 PLXNA3 CACNA1F KAT2B ZNF296 SNAP91 MYCBP2 TRIM32 USP9X ENC1 VPS13A DIAPH1 DIAPH2 POU3F2 SPG11 TECTA PLS1 RUFY3 | 2.33e-05 | 1463 | 85 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 2.59e-05 | 210 | 85 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 3.01e-05 | 215 | 85 | 7 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 3.01e-05 | 215 | 85 | 7 | GO:0001539 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 3.64e-05 | 16 | 85 | 3 | GO:1904181 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ADCY10 PLXNA3 KAT2B ZNF296 SNAP91 MYCBP2 TRIM32 ENC1 DIAPH1 DIAPH2 POU3F2 PLS1 RUFY3 | 4.08e-05 | 846 | 85 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ADCY10 PLXNA3 KAT2B ZNF296 SNAP91 MYCBP2 ENC1 DIAPH1 DIAPH2 POU3F2 RUFY3 | 4.18e-05 | 612 | 85 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ADCY10 PLXNA3 KAT2B ZNF296 SNAP91 MYCBP2 TRIM32 ENC1 DIAPH1 DIAPH2 POU3F2 PLS1 RUFY3 | 5.00e-05 | 863 | 85 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | trophectodermal cell fate commitment | 5.02e-05 | 3 | 85 | 2 | GO:0001830 | |
| GeneOntologyBiologicalProcess | multicellular organismal locomotion | 1.00e-04 | 4 | 85 | 2 | GO:0071965 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X VPS13A DIAPH1 DIAPH2 POU3F2 SPG11 RUFY3 | 1.07e-04 | 802 | 85 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X VPS13A DIAPH1 DIAPH2 POU3F2 SPG11 RUFY3 | 1.30e-04 | 819 | 85 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ADCY10 PLXNA3 CACNA1F SNAP91 MYCBP2 USP9X VPS13A DIAPH1 DIAPH2 POU3F2 SPG11 RUFY3 | 1.41e-04 | 826 | 85 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | growth | ADCY10 PLXNA3 CACNA1C MYCBP2 TRIM32 USP9X VPS13A POU3F2 SPG11 POU5F1 POU5F1B PRKDC ATM PLS1 RUFY3 | 1.44e-04 | 1235 | 85 | 15 | GO:0040007 |
| GeneOntologyBiologicalProcess | ectodermal cell fate commitment | 1.66e-04 | 5 | 85 | 2 | GO:0001712 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.66e-04 | 5 | 85 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 1.95e-04 | 493 | 85 | 9 | GO:0007018 | |
| GeneOntologyBiologicalProcess | axon extension | 2.40e-04 | 135 | 85 | 5 | GO:0048675 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.77e-04 | 217 | 85 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 3.44e-04 | 421 | 85 | 8 | GO:0048638 | |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 3.48e-04 | 7 | 85 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | ectoderm formation | 3.48e-04 | 7 | 85 | 2 | GO:0001705 | |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 3.48e-04 | 7 | 85 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 4.05e-04 | 233 | 85 | 6 | GO:0031345 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.37e-04 | 36 | 85 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | ectodermal cell differentiation | 5.93e-04 | 9 | 85 | 2 | GO:0010668 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 5.93e-04 | 9 | 85 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.93e-04 | 93 | 85 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | telomere capping | 6.43e-04 | 41 | 85 | 3 | GO:0016233 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 6.73e-04 | 169 | 85 | 5 | GO:0010977 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 7.04e-04 | 359 | 85 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 7.39e-04 | 10 | 85 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 9.01e-04 | 11 | 85 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 9.01e-04 | 11 | 85 | 2 | GO:0045955 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.88e-06 | 25 | 84 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | cilium | TNPO1 ADCY10 CACNA1F DNAH12 GLE1 USP9X TTLL11 SLC9B2 VPS13A CFAP69 SLCO6A1 DNAH8 DNAH9 DNAH1 | 1.27e-05 | 898 | 84 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | motile cilium | ADCY10 DNAH12 SLC9B2 VPS13A CFAP69 SLCO6A1 DNAH8 DNAH9 DNAH1 | 1.27e-05 | 355 | 84 | 9 | GO:0031514 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.48e-05 | 46 | 84 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | 4.51e-05 | 235 | 84 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.88e-05 | 238 | 84 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | dynein complex | 6.58e-05 | 54 | 84 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.14e-04 | 73 | 84 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | inner dynein arm | 7.03e-04 | 10 | 84 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1C CACNA1D KAT2B DNAH12 TRIM32 TRPC1 TTLL11 DIAPH1 DIAPH2 DNAH8 DNAH9 PLS1 DNAH1 | 8.16e-04 | 1179 | 84 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 8.20e-04 | 378 | 84 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1C CACNA1D KAT2B DNAH12 TRIM32 TRPC1 TTLL11 DIAPH1 DIAPH2 DNAH8 DNAH9 PLS1 DNAH1 | 8.69e-04 | 1187 | 84 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.03e-03 | 12 | 84 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.03e-03 | 12 | 84 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | axoneme | 1.49e-03 | 207 | 84 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.52e-03 | 208 | 84 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.72e-03 | 214 | 84 | 5 | GO:0036126 | |
| Domain | POU | 6.45e-09 | 16 | 83 | 5 | SM00352 | |
| Domain | POU_2 | 6.45e-09 | 16 | 83 | 5 | PS00465 | |
| Domain | POU_dom | 6.45e-09 | 16 | 83 | 5 | IPR000327 | |
| Domain | POU_3 | 6.45e-09 | 16 | 83 | 5 | PS51179 | |
| Domain | Pou | 6.45e-09 | 16 | 83 | 5 | PF00157 | |
| Domain | POU_1 | 6.45e-09 | 16 | 83 | 5 | PS00035 | |
| Domain | POU | 9.10e-09 | 17 | 83 | 5 | IPR013847 | |
| Domain | CAC1F_C | 8.46e-08 | 3 | 83 | 3 | IPR031688 | |
| Domain | CAC1F_C | 8.46e-08 | 3 | 83 | 3 | PF16885 | |
| Domain | - | 1.15e-07 | 27 | 83 | 5 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 1.68e-07 | 29 | 83 | 5 | IPR010982 | |
| Domain | VDCC_L_a1su | 3.37e-07 | 4 | 83 | 3 | IPR005446 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.51e-07 | 14 | 83 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 3.51e-07 | 14 | 83 | 4 | IPR013602 | |
| Domain | DHC_N2 | 3.51e-07 | 14 | 83 | 4 | PF08393 | |
| Domain | AAA_8 | 3.51e-07 | 14 | 83 | 4 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.51e-07 | 14 | 83 | 4 | IPR011704 | |
| Domain | AAA_5 | 3.51e-07 | 14 | 83 | 4 | PF07728 | |
| Domain | DHC_fam | 4.77e-07 | 15 | 83 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 4.77e-07 | 15 | 83 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 4.77e-07 | 15 | 83 | 4 | PF03028 | |
| Domain | VDCC_a1su_IQ | 2.92e-06 | 7 | 83 | 3 | IPR014873 | |
| Domain | GPHH | 2.92e-06 | 7 | 83 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.92e-06 | 7 | 83 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.92e-06 | 7 | 83 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.92e-06 | 7 | 83 | 3 | PF08763 | |
| Domain | Channel_four-helix_dom | 5.36e-06 | 57 | 83 | 5 | IPR027359 | |
| Domain | - | 5.36e-06 | 57 | 83 | 5 | 1.20.120.350 | |
| Domain | VDCCAlpha1 | 9.93e-06 | 10 | 83 | 3 | IPR002077 | |
| Domain | Ion_trans_dom | 1.17e-05 | 114 | 83 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.17e-05 | 114 | 83 | 6 | PF00520 | |
| Domain | Dynein_HC_stalk | 2.97e-05 | 14 | 83 | 3 | IPR024743 | |
| Domain | MT | 2.97e-05 | 14 | 83 | 3 | PF12777 | |
| Domain | Drf_DAD | 5.84e-05 | 3 | 83 | 2 | IPR010465 | |
| Domain | POU_dom_5 | 5.84e-05 | 3 | 83 | 2 | IPR015585 | |
| Domain | Drf_DAD | 5.84e-05 | 3 | 83 | 2 | PF06345 | |
| Domain | TF_POU_3 | 1.16e-04 | 4 | 83 | 2 | IPR016362 | |
| Domain | MeTrfase | 1.16e-04 | 4 | 83 | 2 | IPR026113 | |
| Domain | ARM-type_fold | 1.31e-04 | 339 | 83 | 8 | IPR016024 | |
| Domain | FATC | 1.93e-04 | 5 | 83 | 2 | PF02260 | |
| Domain | Methyltransf_12 | 2.89e-04 | 6 | 83 | 2 | PF08242 | |
| Domain | FAT | 2.89e-04 | 6 | 83 | 2 | PS51189 | |
| Domain | FATC | 2.89e-04 | 6 | 83 | 2 | PS51190 | |
| Domain | FAT | 2.89e-04 | 6 | 83 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 2.89e-04 | 6 | 83 | 2 | IPR003151 | |
| Domain | FATC_dom | 2.89e-04 | 6 | 83 | 2 | IPR003152 | |
| Domain | PIK_FAT | 2.89e-04 | 6 | 83 | 2 | IPR014009 | |
| Domain | Methyltransf_12 | 2.89e-04 | 6 | 83 | 2 | IPR013217 | |
| Domain | FATC | 2.89e-04 | 6 | 83 | 2 | SM01343 | |
| Domain | DAD_dom | 5.37e-04 | 8 | 83 | 2 | IPR014767 | |
| Domain | DHC_N1 | 5.37e-04 | 8 | 83 | 2 | PF08385 | |
| Domain | DAD | 5.37e-04 | 8 | 83 | 2 | PS51231 | |
| Domain | Dynein_heavy_dom-1 | 5.37e-04 | 8 | 83 | 2 | IPR013594 | |
| Domain | Drf_GBD | 6.88e-04 | 9 | 83 | 2 | PF06371 | |
| Domain | FH3_dom | 6.88e-04 | 9 | 83 | 2 | IPR010472 | |
| Domain | GTPase-bd | 6.88e-04 | 9 | 83 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 6.88e-04 | 9 | 83 | 2 | PF06367 | |
| Domain | Drf_FH3 | 6.88e-04 | 9 | 83 | 2 | SM01139 | |
| Domain | Drf_GBD | 6.88e-04 | 9 | 83 | 2 | SM01140 | |
| Domain | GBD/FH3_dom | 1.05e-03 | 11 | 83 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 1.05e-03 | 11 | 83 | 2 | PS51232 | |
| Domain | GrpE_coiled_coil | 1.25e-03 | 12 | 83 | 2 | IPR013805 | |
| Domain | Homeobox_CS | 1.44e-03 | 186 | 83 | 5 | IPR017970 | |
| Domain | FH2 | 1.97e-03 | 15 | 83 | 2 | PS51444 | |
| Domain | PI3/4_kinase_CS | 1.97e-03 | 15 | 83 | 2 | IPR018936 | |
| Domain | FH2_Formin | 1.97e-03 | 15 | 83 | 2 | IPR015425 | |
| Domain | FH2 | 1.97e-03 | 15 | 83 | 2 | PF02181 | |
| Domain | FH2 | 1.97e-03 | 15 | 83 | 2 | SM00498 | |
| Domain | - | 2.25e-03 | 16 | 83 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.25e-03 | 16 | 83 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.85e-03 | 18 | 83 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.85e-03 | 18 | 83 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.85e-03 | 18 | 83 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.85e-03 | 18 | 83 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.85e-03 | 18 | 83 | 2 | PS00916 | |
| Domain | - | 3.11e-03 | 222 | 83 | 5 | 1.25.10.10 | |
| Domain | Homeobox | 3.89e-03 | 234 | 83 | 5 | PF00046 | |
| Domain | AAA+_ATPase | 3.89e-03 | 144 | 83 | 4 | IPR003593 | |
| Domain | AAA | 3.89e-03 | 144 | 83 | 4 | SM00382 | |
| Domain | HOMEOBOX_1 | 4.03e-03 | 236 | 83 | 5 | PS00027 | |
| Domain | HOX | 4.10e-03 | 237 | 83 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 4.25e-03 | 239 | 83 | 5 | PS50071 | |
| Domain | Homeobox_dom | 4.25e-03 | 239 | 83 | 5 | IPR001356 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.38e-06 | 6 | 59 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.52e-06 | 27 | 59 | 4 | M47755 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.45e-05 | 14 | 59 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.02e-05 | 43 | 59 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.63e-05 | 45 | 59 | 4 | M47670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.16e-04 | 23 | 59 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.50e-04 | 25 | 59 | 3 | M47948 | |
| Pathway | PID_BARD1_PATHWAY | 2.36e-04 | 29 | 59 | 3 | M258 | |
| Pathway | WP_MIRNAS_AND_TFS_IN_IPS_CELL_GENERATION | 4.74e-04 | 8 | 59 | 2 | MM15855 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 21185279 | ||
| Pubmed | Oct4 expression is not required for mouse somatic stem cell self-renewal. | 1.41e-08 | 3 | 85 | 3 | 18159219 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 15917470 | ||
| Pubmed | TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stability. | 1.41e-08 | 3 | 85 | 3 | 26307407 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 20937870 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 16354795 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 23437007 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 10199551 | ||
| Pubmed | Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors. | 2.80e-07 | 6 | 85 | 3 | 29742392 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 15262984 | ||
| Pubmed | 4.77e-07 | 26 | 85 | 4 | 22992956 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 18682553 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 9256245 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 12900400 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 8900043 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 19147497 | ||
| Pubmed | SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. | 1.17e-06 | 9 | 85 | 3 | 17187077 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 21559298 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 35410378 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 18809727 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.30e-06 | 38 | 85 | 4 | 30786075 | |
| Pubmed | MYCBP2 TRIM32 USP9X ENC1 PDZD8 LMO3 EWSR1 PRKDC ATM ZFC3H1 EIF2AK1 LRRC4 INTS8 RUFY3 | 2.70e-06 | 1285 | 85 | 14 | 35914814 | |
| Pubmed | RNA Pol II pausing facilitates phased pluripotency transitions by buffering transcription. | 3.05e-06 | 12 | 85 | 3 | 35981753 | |
| Pubmed | Essential and overlapping functions for mammalian Argonautes in microRNA silencing. | 3.05e-06 | 12 | 85 | 3 | 19174539 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 27292645 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.64e-06 | 497 | 85 | 9 | 36774506 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 15273690 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 9373155 | ||
| Pubmed | 5.47e-06 | 47 | 85 | 4 | 8812413 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15685634 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16950240 | ||
| Pubmed | Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. | 5.90e-06 | 2 | 85 | 2 | 18837968 | |
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 5.90e-06 | 2 | 85 | 2 | 11231155 | |
| Pubmed | Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. | 5.90e-06 | 2 | 85 | 2 | 33810223 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 5.90e-06 | 2 | 85 | 2 | 18932201 | |
| Pubmed | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. | 5.90e-06 | 2 | 85 | 2 | 1972777 | |
| Pubmed | Mouse Oct-3 maps between the tcl12 embryonic lethal gene and the Qa gene in the H-2 complex. | 5.90e-06 | 2 | 85 | 2 | 1680810 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15996113 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26804242 | ||
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 5.90e-06 | 2 | 85 | 2 | 10464290 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21502535 | ||
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 5.90e-06 | 2 | 85 | 2 | 27939942 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11839818 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 33221301 | ||
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 5.90e-06 | 2 | 85 | 2 | 12641567 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 14992721 | ||
| Pubmed | A nontranscriptional role for Oct4 in the regulation of mitotic entry. | 5.90e-06 | 2 | 85 | 2 | 25324523 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 5.90e-06 | 2 | 85 | 2 | 18765667 | |
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 5.90e-06 | 2 | 85 | 2 | 18283123 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21054386 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34463738 | ||
| Pubmed | Differential expression of Oct3/4 in human breast cancer and normal tissues. | 5.90e-06 | 2 | 85 | 2 | 29620155 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21487018 | ||
| Pubmed | Glutamine Metabolism Regulates the Pluripotency Transcription Factor OCT4. | 5.90e-06 | 2 | 85 | 2 | 27346346 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19559696 | ||
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 5.90e-06 | 2 | 85 | 2 | 26057167 | |
| Pubmed | Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. | 5.90e-06 | 2 | 85 | 2 | 26877091 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12615074 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22367590 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22739622 | ||
| Pubmed | Oct-4: more than just a POUerful marker of the mammalian germline? | 5.90e-06 | 2 | 85 | 2 | 9524569 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25748933 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 5.90e-06 | 2 | 85 | 2 | 25966695 | |
| Pubmed | Expression pattern of Oct-4 in preimplantation embryos of different species. | 5.90e-06 | 2 | 85 | 2 | 11090438 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32994224 | ||
| Pubmed | Networks of Transcription Factors for Oct4 Expression in Mice. | 5.90e-06 | 2 | 85 | 2 | 28731785 | |
| Pubmed | Oct-4 controls cell-cycle progression of embryonic stem cells. | 5.90e-06 | 2 | 85 | 2 | 19968627 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23629142 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12702663 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24086669 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35501657 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26832419 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 5.90e-06 | 2 | 85 | 2 | 26049024 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22120493 | ||
| Pubmed | Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. | 5.90e-06 | 2 | 85 | 2 | 26435056 | |
| Pubmed | Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. | 5.90e-06 | 2 | 85 | 2 | 9507072 | |
| Pubmed | Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. | 5.90e-06 | 2 | 85 | 2 | 15548425 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36130732 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31222057 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19071136 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9835353 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19225208 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30209362 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 5.90e-06 | 2 | 85 | 2 | 16706838 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34788058 | ||
| Pubmed | Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. | 5.90e-06 | 2 | 85 | 2 | 17525163 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23761887 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 14981074 | ||
| Pubmed | Function of EWS-POU5F1 in sarcomagenesis and tumor cell maintenance. | 5.90e-06 | 2 | 85 | 2 | 20203285 | |
| Pubmed | Auxin-degron system identifies immediate mechanisms of OCT4. | 5.90e-06 | 2 | 85 | 2 | 34143975 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27302093 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 5.90e-06 | 2 | 85 | 2 | 25292336 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12065055 | ||
| Pubmed | Force via integrins but not E-cadherin decreases Oct3/4 expression in embryonic stem cells. | 5.90e-06 | 2 | 85 | 2 | 22037576 | |
| Pubmed | Oct4 redox sensitivity potentiates reprogramming and differentiation. | 5.90e-06 | 2 | 85 | 2 | 38719541 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17526649 | ||
| Pubmed | A unique Oct4 interface is crucial for reprogramming to pluripotency. | 5.90e-06 | 2 | 85 | 2 | 23376973 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23580657 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12606379 | ||
| Interaction | POU3F3 interactions | 1.68e-06 | 22 | 81 | 4 | int:POU3F3 | |
| Interaction | CACNA1D interactions | 2.42e-06 | 24 | 81 | 4 | int:CACNA1D | |
| Interaction | USF1 interactions | 2.36e-05 | 85 | 81 | 5 | int:USF1 | |
| Interaction | SCN11A interactions | 2.75e-05 | 15 | 81 | 3 | int:SCN11A | |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.78e-08 | 23 | 66 | 5 | 523 | |
| GeneFamily | Dyneins, axonemal | 3.72e-07 | 17 | 66 | 4 | 536 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.14e-04 | 26 | 66 | 3 | 253 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-08 | 162 | 84 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-05 | 155 | 84 | 5 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 1.20e-05 | 157 | 84 | 5 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 159 | 84 | 5 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 165 | 84 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 165 | 84 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.64e-05 | 185 | 84 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 186 | 84 | 5 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 186 | 84 | 5 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 186 | 84 | 5 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 3.48e-05 | 196 | 84 | 5 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.57e-05 | 197 | 84 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | 1c78bd52b94a9466459a645ac9bd14bac22c54bd | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.65e-05 | 198 | 84 | 5 | 9b1a58fcf818f9c4ae57bbe99655f0a64fe87df7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.74e-05 | 199 | 84 | 5 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.74e-05 | 199 | 84 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 3.74e-05 | 199 | 84 | 5 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.74e-05 | 199 | 84 | 5 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Drug | Cinnarizine | 4.00e-06 | 9 | 84 | 3 | DB00568 | |
| Drug | Nimodipine | 4.00e-06 | 9 | 84 | 3 | DB00393 | |
| Drug | benzilate | 4.54e-06 | 66 | 84 | 5 | CID000201538 | |
| Drug | CAS 298-57-7 | 7.47e-06 | 73 | 84 | 5 | CID000002761 | |
| Drug | Mibefradil | 7.82e-06 | 11 | 84 | 3 | DB01388 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 4374_UP | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.99e-06 | 199 | 84 | 7 | 3485_DN | |
| Drug | Verapamil | 2.62e-05 | 16 | 84 | 3 | DB00661 | |
| Drug | mercury | CACNA1C CACNA1D CDAN1 CACNA1F ACRV1 TLR1 TXNRD3 DEPDC1 POU2F3 DNAH1 | 3.06e-05 | 542 | 84 | 10 | CID000023931 |
| Drug | KW-3049 | 3.49e-05 | 50 | 84 | 4 | CID000002324 | |
| Drug | hexamidine | 4.50e-05 | 19 | 84 | 3 | CID000065130 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 7.96e-08 | 4 | 81 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | Manic | 6.44e-05 | 78 | 81 | 4 | C0338831 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.33e-04 | 36 | 81 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.83e-04 | 40 | 81 | 3 | C0598589 | |
| Disease | hydroxy-leucine measurement | 2.60e-04 | 45 | 81 | 3 | EFO_0005276 | |
| Disease | response to virus | 4.03e-04 | 11 | 81 | 2 | GO_0009615 | |
| Disease | Endometrial Neoplasms | 5.51e-04 | 58 | 81 | 3 | C0014170 | |
| Disease | early cardiac repolarization measurement | 6.63e-04 | 14 | 81 | 2 | EFO_0004885 | |
| Disease | Manic Disorder | 9.96e-04 | 71 | 81 | 3 | C0024713 | |
| Disease | Endometrial Carcinoma | 1.04e-03 | 72 | 81 | 3 | C0476089 | |
| Disease | Mood Disorders | 1.20e-03 | 168 | 81 | 4 | C0525045 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.23e-03 | 19 | 81 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 1.23e-03 | 19 | 81 | 2 | C2936783 | |
| Disease | Depression, Bipolar | 1.36e-03 | 79 | 81 | 3 | C0005587 | |
| Disease | attempted suicide | 1.48e-03 | 178 | 81 | 4 | EFO_0004321 | |
| Disease | Immunologic Deficiency Syndromes | 1.81e-03 | 23 | 81 | 2 | C0021051 | |
| Disease | Deafness | 2.14e-03 | 25 | 81 | 2 | C0011053 | |
| Disease | reticulocyte count | 2.25e-03 | 1045 | 81 | 9 | EFO_0007986 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.32e-03 | 26 | 81 | 2 | C0009405 | |
| Disease | Adenocarcinoma of large intestine | 2.37e-03 | 96 | 81 | 3 | C1319315 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.50e-03 | 27 | 81 | 2 | C1112155 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIKRKLCFALSMLGN | 1436 | Q8WWZ7 | |
| DLADFFKQCGVVKMN | 376 | Q01844 | |
| KENKCLLMSFFILLL | 76 | P19397 | |
| AKFKQDLGFRMLNCG | 566 | A6QL63 | |
| LLFDFLEVCGNALMK | 621 | Q53GS7 | |
| AFMLLFKDLIKLFAC | 196 | O60641 | |
| INLLEKFFEMKKGQC | 216 | O60641 | |
| QINKVFMFDKGCSFL | 331 | Q96PN6 | |
| EIIRCLKAFMNNKFG | 216 | O60610 | |
| CLKAFMNNKFGLQRI | 236 | O60879 | |
| QESEGKMCFLNKLLL | 731 | Q8IWY9 | |
| QCMLKKIFEGGKLQF | 216 | P26436 | |
| KGNMAAFLKNVCLGL | 436 | Q75QN2 | |
| FTHNMLAFGLNKKLC | 366 | O60268 | |
| RFEALQLSFKNMCKL | 186 | Q06416 | |
| QFMFACIGVQLFKGK | 1011 | O60840 | |
| KLFMADLQRVFTNCK | 786 | Q92831 | |
| EMLKFNLECLHKTFG | 36 | O95050 | |
| FLAAGKLVLLQEMCA | 126 | Q8TDN1 | |
| MGQLLKCLKDFAFNI | 1646 | Q5H9U9 | |
| FKSLADGILLCKMIN | 156 | Q14651 | |
| GLMLQEADKLGCKQF | 336 | Q14651 | |
| LFLLYCAIKQQMEKG | 1436 | P51805 | |
| LLFCIQEGVKMFLKQ | 336 | Q9UHC1 | |
| LRNLSMQKGFNDKFC | 771 | Q8NEN9 | |
| LDMFNQLLKKISDLC | 701 | Q96JB1 | |
| YDMAQLRFKKGQCLS | 296 | Q6P1Q9 | |
| GFQERCAKKMQLVNL | 371 | Q5TB30 | |
| CNELLEKIMKGLNAY | 971 | Q6ZR08 | |
| FEALQLSFKNMCKLK | 296 | Q03052 | |
| RFCVGDKFFLKNNMI | 111 | Q8TAP4 | |
| FNLKYLNLGMCNIKD | 196 | Q9HBW1 | |
| QKALKMILTCAGVFL | 226 | Q9BXC1 | |
| GLLICRFNNFSLMKK | 1726 | Q9C091 | |
| RFEALNLSFKNMCKL | 231 | Q9UKI9 | |
| RFEALQLSFKNMCKL | 186 | Q01860 | |
| YDMAQLRFKKGQCLS | 296 | Q96IZ6 | |
| FKMQLLKGGQILCDL | 51 | Q9Y6W8 | |
| ADQALQMLFKPLGKC | 406 | C9JE40 | |
| NLTMSLLKLLDCFFK | 2066 | Q9P2D7 | |
| SKQDLLFLDMLKFLC | 891 | Q13315 | |
| KANIMKLGDGLFLQC | 221 | P51553 | |
| FMFACIGVQLFKGKL | 1061 | Q13936 | |
| FKLLCQTFIKMGLLS | 91 | Q9BQI3 | |
| NFLLKFQGIKMCGKE | 176 | P05937 | |
| QEKCLLFSKQFMHQG | 631 | Q5T0F9 | |
| NKGACILNMLKDFLG | 456 | Q6P179 | |
| ALFLLGGQTFMCDKL | 296 | O14682 | |
| QIQDFKMDLASLCLK | 2856 | Q9NYC9 | |
| MKLGKVEFCHFLQLI | 1 | Q9ULB5 | |
| NQKKFCNLILGIMVE | 621 | A5D8W1 | |
| QFMFACIGVQLFKGK | 1026 | Q01668 | |
| LMQFCANKLDKKDFF | 161 | Q86YQ8 | |
| QKLNHFFCEIMAVLK | 171 | A4D2G3 | |
| CMKGFQFQKKDFNLL | 1201 | Q16363 | |
| LKEIDFKACLAQMFF | 91 | Q8NH53 | |
| QAGKLFCDIAGMLLK | 746 | Q9Y6R4 | |
| LLVGLNVIDANFCMK | 211 | Q7L099 | |
| NLRSLENKPVFMFCK | 251 | P0DSN6 | |
| QFMKKLLTCNGVYLN | 2011 | Q93008 | |
| NIQQCLFLKKMGAKG | 351 | Q13049 | |
| FNKDKAISFLGCMVQ | 86 | Q8NGL2 | |
| TFLMVCFAGFNLKEK | 436 | Q86UD5 | |
| LIGLQLFMGNLKHKC | 261 | Q15858 | |
| LFMGNLKHKCFRNSL | 266 | Q15858 | |
| NCFKVMFLQRKGQVI | 951 | O75182 | |
| NKTKMAFLLVGICFL | 661 | Q86UG4 | |
| NKLGILDMFLGCIAK | 4101 | O75592 | |
| FEALQLSFKNMCKLK | 311 | P20265 | |
| FNKDKAISFLGCMVQ | 86 | Q8NGL0 | |
| ICKEFGNMSQLKFLG | 131 | Q15399 | |
| CEGFFLKHMKALLEQ | 971 | Q8N961 | |
| KNMGFDVKGQLLKIC | 746 | Q96JI7 | |
| MEVSISKCKLFQLGF | 1811 | O75443 | |
| LARQCKMFAKDLLAQ | 261 | P48995 | |
| VLGDFLCKLLNMIFS | 96 | P46094 | |
| CFQILGFDILLMKNL | 511 | Q8NHH1 | |
| NCEMFLNFNGMKLFL | 561 | Q7Z7L7 | |
| LNFNGMKLFLDCLKE | 566 | Q7Z7L7 | |
| SKCGLVMLNNLVKAF | 1846 | Q96RL7 | |
| TMCGFNLFFKIKARD | 161 | Q8N4F7 | |
| CNSLMKKLQHLFAFL | 481 | Q8NB14 | |
| DLRDMFCKILHGFKN | 856 | Q92973 | |
| LKFLCIFLEKMGQKI | 86 | P78527 | |
| FAAAMKCGLTKQLLD | 596 | Q86VQ6 | |
| FKKMVQGVLQFAVCD | 2076 | Q9C0G0 | |
| LCAQDLKDLVGIFKM | 341 | Q8N9V3 | |
| MCKFFILQNRGDNLL | 1676 | O60293 | |
| ITAFMDHKKLGCQLF | 126 | Q8WUU4 | |
| TQMKCFLFGLLNEDR | 526 | Q86W24 |